OpenAlex
PricingAboutJobs
Log inGet started
Work

Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug

HTML

Year: 2013
Type: article
Source: Blood
DOI: 10.1182/blood-2013-03-490482
Authors: Jacob M. Rowe, Bob Löwenberg
Institutions: Technion – Israel Institute of Technology, Shaare Zedek Medical Center, Bikur Cholim Hospital, Erasmus MC
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: gemtuzumab ozogamicin, acute myeloid leukemia, newly diagnosed AML, relapsed AML, drug efficacy, drug toxicity, accelerated FDA approval, monoclonal antibody-drug conjugate
SDG: Good health and well-being

Open Access status: closed

Funder: American Society of Hematology
OpenAlex ID: W2004530843
FWCI: 12.87
Cites: 18
Cited by: 156
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security